Posted by Michael Wonder on 08 Feb 2024
J&J, Merck and Bristol Myers CEOs defend high drug prices in Senate hearing, as Biden tries to cut costs
8 February 2024 - The CEOs of Johnson & Johnson, Merck and Bristol Myers Squibb defended high drug prices in the US at a Senate hearing.
The push to cut drug prices is one of the rare hot button issues that unites the two major political parties, though they often back different approaches to reducing costs.
